Proxy Results (Form 8-K)

Item 5.07. Submission of Matters to a Vote of Security Holders.

On November 10, 2026, BioVie Inc. (the "Company") held its 2026 annual meeting of stockholders (the "Annual Meeting"). On September 21, 2026, the record date for stockholders entitled to notice of, and to vote at, the Annual Meeting, 8,682,710 shares of the Company's Class A common stock ("Common Stock") were outstanding. The holders of 4,749,367 shares of Common Stock were present at the Annual Meeting, either virtually or represented by proxy, constituting a quorum.

The following matters were considered at the Annual Meeting and the final voting results are set forth below:

Stockholders elected all of the Company's nominees for director to hold office until the next annual meeting of stockholders and until their respective successors are elected and qualified. The voting results were as follows:

Stockholders ratified the appointment of EisnerAmper LLP as the Company's independent registered public accounting firm for the fiscal year ending June 30, 2027. The voting results were as follows:

Stockholders approved an amendment and restatement of the 2019 Omnibus Equity Incentive Plan to increase the number of shares of Common stock available for issuance pursuant to awards granted thereunder from 399,509 to 3,100,000. The voting results were as follows: